Anna Cargnoni | Excellence in Scientific Innovation Award | Medicina Rigenerativa

Excellence in Scientific Innovation Award

Anna Cargnoni
Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero, Italy

Anna Cargnoni
Affiliation Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero
Country Italy
Scopus ID 7003835086
Documents 124
Citations 4,544
h-index 34
Subject Area Medicina Rigenerativa
Event International Academic Achievements & Awards
ORCID 0000-0002-8617-1139

Anna Cargnoni is a researcher affiliated with the Centro di Ricerca Eugenia Menni and Fondazione Poliambulanza Istituto Ospedaliero in Italy. Her indexed scholarly profile is associated with research in the area identified as Medicina Rigenerativa (Regenerative Medicine). The supplied Scopus record reports 124 documents, 4,544 citations and an h-index of 34, providing quantitative indicators of her indexed research output and scholarly visibility. [1]

Abstract

The Excellence in Scientific Innovation Award recognizes research performance characterized by sustained scholarly activity, scientific contribution and measurable academic impact. Anna Cargnoni is presented for consideration on the basis of the supplied bibliographic and indexing information associated with her research profile. Her record comprises 124 documents, 4,544 citations and an h-index of 34 in Scopus, with regenerative medicine identified as the principal subject area. [1] These indicators provide an objective starting point for evaluating publication productivity and citation-based influence, while qualitative assessment should additionally consider originality, methodological rigor, translational relevance and contribution to the scientific community.

Keywords

Anna Cargnoni; Excellence in Scientific Innovation Award; Regenerative Medicine; Medicina Rigenerativa; scientific innovation; biomedical research; scholarly impact; research publications; citation impact; Scopus; h-index.

Introduction

Scientific innovation in regenerative medicine encompasses research directed toward understanding tissue repair, biological restoration and the development or evaluation of approaches capable of addressing unmet biomedical needs. Academic recognition in this field generally requires consideration of both the quality of individual scientific contributions and the broader continuity of a researcher’s scholarly record.

The supplied researcher information places Anna Cargnoni within an Italian institutional research environment and associates her work with regenerative medicine. Her bibliometric profile indicates a substantial body of indexed scholarly output and citation activity. [1] Such metrics can support an award assessment, although they are most appropriately interpreted together with evidence concerning research originality, scientific methodology, collaboration, dissemination and practical significance.

Research Profile

The academic profile supplied for Anna Cargnoni is associated with the Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero in Italy. The reported Scopus author identifier is 7003835086. The indexed record supplied for this article contains 124 documents, 4,544 citations and an h-index of 34. [1]

  • Research domain: Medicina Rigenerativa / Regenerative Medicine.
  • Institutional affiliation: Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero.
  • Country of affiliation: Italy.
  • Scopus-indexed documents reported: 124.
  • Scopus-indexed citations reported: 4,544.
  • Reported h-index: 34.

Research Contributions

Within the stated field of regenerative medicine, scientific contribution can be assessed through the development of new knowledge, reproducible research methods, interdisciplinary collaboration and the potential translation of findings into biomedical practice. The available profile data establish a substantial indexed publication and citation record, but bibliometric indicators alone do not identify the specific scientific findings or individual contributions contained within each publication. Accordingly, detailed claims about particular discoveries should be based on the underlying publications and verified bibliographic records.

For an academic award assessment, relevant evidence may include the originality of research questions, methodological robustness, contribution to collaborative projects, quality of peer-reviewed publications, citation performance relative to the relevant field, and demonstrated influence on subsequent research. These dimensions complement the quantitative indicators reported in the supplied Scopus profile. [1]

Publications

The supplied publication information includes an article titled “Selecting after sales provider of complex product based on game and matching framework”, authored by, and published in Engineering Applications of Artificial Intelligence in 2025. This publication is listed here as part of the supplied article information; the available input does not establish that Anna Cargnoni is an author of this particular work. It should therefore not be attributed to her without verification against the original bibliographic record.

Research Impact

The reported citation count and h-index indicate that the research record associated with Scopus Author ID 7003835086 has achieved measurable visibility within the indexed scholarly literature. The reported 4,544 citations and h-index of 34 provide quantitative evidence that multiple publications have been cited by other scholarly works. [1]

Bibliometric measures should nevertheless be interpreted within disciplinary and temporal context. Citation counts can vary substantially among research fields, publication types and years of publication. For a comprehensive assessment of scientific impact, these indicators should therefore be supplemented by evidence such as influential research findings, collaboration networks, translational outcomes, research adoption and contributions to the development of the field.

Award Suitability

The available profile provides several measurable elements relevant to consideration for the Excellence in Scientific Innovation Award. The assessment should remain evidence-based and should distinguish verified bibliometric information from qualitative conclusions requiring review of the underlying research.

  • Research productivity: the supplied profile reports 124 Scopus-indexed documents. [1]
  • Scholarly visibility: the supplied profile reports 4,544 citations. [1]
  • Research influence: an h-index of 34 is reported for the Scopus author profile. [1]
  • Subject alignment: the stated subject area, Medicina Rigenerativa, is directly relevant to biomedical and regenerative research.
  • Institutional research context: the supplied affiliation connects the profile with an established Italian healthcare and research institution.
  • Further evaluation: originality, research quality, methodological rigor, scientific contribution and broader impact should be examined through the underlying publications and supporting evidence.

Conclusion

Anna Cargnoni’s supplied academic profile presents a substantial indexed research record in the area of Medicina Rigenerativa. The reported figures of 124 documents, 4,544 citations and an h-index of 34 provide quantifiable indicators of scholarly productivity and citation impact. [1] These indicators support consideration for the Excellence in Scientific Innovation Award, while a final recognition decision should incorporate independent evaluation of the originality, quality, relevance and documented scientific contribution of the research.

References

  1. Elsevier. (n.d.). Scopus author details: Anna Cargnoni, Author ID 7003835086. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7003835086
  2. ORCID. (n.d.). ORCID record associated with the supplied researcher profile.https://orcid.org/0000-0002-8617-1139

Noury Adel | Aesthetic Medicine | Young Scientist Award

Dr. Noury Adel | Aesthetic Medicine | Young Scientist Award 

Dr. Noury Adel | Aesthetic Medicine | Researcher at Cairo University | Egypt

Aesthetic Medicine defines the forefront of Dr. Noury Adel’s professional and academic journey, establishing him as a leading Oral and Maxillofacial Surgery Specialist, Key Opinion Leader, international speaker, and editorial board member with extensive contributions to both clinical practice and research innovation. Dr. Noury Adel completed his Bachelor’s degree at Future University in Egypt, laying a strong foundation in health sciences, followed by a Master’s degree in Oral and Maxillofacial Surgery at Al Azhar University, where he honed his surgical expertise and advanced treatment methodologies, and further enhanced his leadership and healthcare management skills with a Diploma in Hospital Management from Ain Shams University. Over the years, Dr. Noury Adel has cultivated an impressive professional portfolio, performing complex oral and maxillofacial procedures while integrating cutting-edge regenerative and aesthetic approaches, including innovative use of plant-derived exosomes, hyaluronic acid boosters, and laser-assisted therapies to optimize patient outcomes. His research interests lie at the intersection of regenerative medicine, wound healing, facial rejuvenation, and minimally invasive interventions, with a particular focus on the translational application of bioactive compounds for tissue repair and aesthetic restoration. Dr. Noury Adel possesses strong research skills encompassing experimental study design, histological and cellular analysis, clinical trial methodology, laser-assisted therapy protocols, and advanced injection techniques, all of which underpin his contributions to numerous high-impact publications and collaborative scientific projects. As a prolific author, he has led investigations on novel approaches to skin wound healing, interdental papillary regeneration, management of bruxism, and synergistic bioregenerative techniques for lip and periorbital rejuvenation, establishing standardized methodologies that bridge aesthetic medicine with oral surgical practice. His professional recognition includes invitations as an international speaker, active roles in editorial boards, peer review contributions, and keynote presentations at global conferences, reflecting both the clinical significance and academic impact of his work. Dr. Noury Adel’s awards and honors further underscore his excellence in clinical practice, research innovation, and contributions to the field of aesthetic medicine, highlighting his commitment to advancing patient care and medical education. Through a combination of rigorous training, translational research, and clinical mastery, Dr. Noury Adel has become a trusted authority in aesthetic medicine and oral surgery, demonstrating a unique ability to integrate scientific evidence with practical application to deliver safe, effective, and cutting-edge treatments. His career embodies a dedication to advancing the field of aesthetic medicine, fostering innovation in regenerative therapies, and mentoring the next generation of clinicians and researchers, ensuring sustained progress in both surgical and cosmetic medicine. In conclusion, Dr. Noury Adel represents the convergence of expertise, innovation, and leadership, continually driving advancements in aesthetic medicine, oral and maxillofacial surgery, and regenerative clinical practice on a global scale.

Profile: ORCID

Featured Publications 

  1. Adel, N. (2025). Regenerative potential of various plant-derived exosome injections in laser-induced skin wound healing in a rabbit model.
  2. Adel, N. (2025). Plant-based exosome injections for skin wound healing: Experimental study.
  3. Adel, N. (2025). Plant-based exosomes for skin repair: Modulating inflammatory cell count in an experimental wound model.
  4. Adel, N. (2025). Bruxism management using a multilayered Xeomin injection approach: A comparative study.
  5. Adel, N. (2025). Injection of hyperdiluted Radiesse hybrid with Belotero Balance for interdental papillary regeneration: A novel combined approach.
  6. Adel, N. (2025). Hyaluronic acid skin booster injection and cold laser therapy in oral wounds: An experimental study.
  7. Adel, N. (2025). The Lip Exo-S technique: Synergistic bioregenerative lip boosting with PDRN, exosomes, HA skin boosters, and a hyaluronic acid rejuvenating complex.